Every vaccine must be safe, effective and well-tested before it receives marketing authorisation in the EU or Germany. The manufacturer must provide this proof in pre-clinical studies and clinical trials.
For vaccination against COVID-19, different vaccines are approved in the European Union (EU), which have already been evaluated by the STIKO for different age groups.Two mRNA vaccines (with variants adapted to Omikron), two vector vaccines, two protein-based vaccines, and a whole virus vaccine against SARS-CoV-2 coronavirus are currently licensed in Europe.
Detailed information on this can also be found in the current STIKO recommendations.
Information about possible vaccination reactions is part of the educational discussion prior to the administration of a vaccination.
You can also find relevant information on vaccination reactions in advance on the information pages of the RKI.
It is of great importance for medical research that as many people as possible report on their vaccination and the tolerability of the respective vaccine.
The Federal Institute for Drugs and Medical Devices provides an online form for this purpose.